C12P 21 - Preparation of peptides or proteins

Patents for C12P 21 - Preparation of peptides or proteins (112,499)
10/2006
10/25/2006	EP1714971A2 Directed switch-mediated DNA recombination
10/25/2006	EP1713825A2 Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same
10/25/2006	EP1713503A1 Inhibition of factor b, the alternative complement pathway and methods related thereto
10/25/2006	EP1546368A4 Analytical method for the determination of infant formula protein digestibility in vitro
10/25/2006	EP1423417B1 Antibodies recognizing a peptide mimicking a cryptic epitope of gp41 of hiv-1
10/25/2006	EP1248536B1 Porphyrin containing lactic acid bacterial cells and use thereof
10/25/2006	EP1109901B1 GABA B RECEPTOR SUBTYPES GABA B-R1c AND GABA B-R2 AND HETERODIMERS THEREOF
10/25/2006	EP1107993B1 Human monoclonal antibodies directed against the islet cell antigen ia-2
10/25/2006	EP0977876B1 Nucleic acid molecules from artichoke (cynara scolymus) encoding enzymes having fructosyl polymerase activity
10/25/2006	CN1852987A Process for producing a-glycosylated dipeptide and method of assaying a-glycosylated dipeptide
10/25/2006	CN1852984A A non-denaturing process to purify recombinant proteins from plants
10/25/2006	CN1852981A The anti-platelet membrane glycoprotein VI monoclonal antibody
10/25/2006	CN1852736A Immunoglobulin chimeric monomer-dimer hybrids
10/25/2006	CN1850977A Soluble colibacillus expression plasmid and its use
10/25/2006	CN1850862A Chicken interleukin-2-receptor alpha chain extracellular region protein monoclonal antibody, and its preparing method
10/25/2006	CN1850859A Angiogenin mutant as agonist, and its preparing method
10/25/2006	CN1281747C i(Ehrlichia canis) 120-KDa immunodominant antigenic protein and gene
10/25/2006	CN1281737C Producing basic proteinase by vibrio metschnikovii DL 33-51 strain
10/25/2006	CN1281732C Production of agar-agar enzyme by Alteromonas sp.nov.SY 37-12 strain
10/25/2006	CN1281623C Human alpha interferon derivative with superstrong antiviral activity
10/25/2006	CN1281622C Excreted proteins as indicators related to tumor and application
10/25/2006	CN1281618C Novel depsipeptide compound
10/24/2006	US7125979 Upstream control elements of the proopiomelanocortin gene and their use
10/24/2006	US7125976 Method of screening for agents inhibiting chloride intracellular channels
10/24/2006	US7125971 Full-length genomic RNA of papaya leaf-distortion mosaic virus
10/24/2006	US7125839 Chimeric molecules that contain at least one pathogen-detection domain and at least one effector domain; use in preventing or treating a pathogen infection in a cell or organism
10/24/2006	US7125719 Polypeptides; transgenic plant; stress tolerance
10/24/2006	US7125718 Method for introducing and expressing genes in animal cells, and bacterial blebs for use in same
10/24/2006	US7125715 Nucleic acid encoding a polypeptide promoting type II collagen formation and aggrecan production
10/24/2006	US7125714 Progenitor cell materials and methods
10/24/2006	US7125713 Human mullerian duct-derived epithelial cells and methods of isolation and uses thereof
10/24/2006	US7125712 DNA segment from a BIV genome; a packaging sequence to package RNA into virions; a first promoter operably linked to the DNA segment; d) a transgene operably linked to a second promoter and deletion of vpw, vpy and tat from the construct
10/24/2006	US7125704 Heat resistant, storage stable, and capable of dehydrating D-gluconic acid to produce 2-keto-3-deoxy-D-gluconic acid; particularly derived from Achromobacter xylosoxidans
10/24/2006	US7125702 Preparation of an proteolytic enzymatic hydrolysate of a selected soybean storage protein fraction, glycinin, that evidences potent Angiotensin Converting Enzyme inhibitory activity.
10/24/2006	US7125697 Expression vector containing the polynucleotide; cell transformation; use in diganostics and as substrate for luminescent reactions; coelenterazine
10/24/2006	US7125695 Generating bacterial strain with reversible mutation in gene/s associated with DNA repair; bioreactors and heterologous gene expression
10/24/2006	US7125690 Regulatory nucleotide sequence fro use as tools in controlling heterologous/endogenous transcription; transcriptional regulators and bioreactors
10/24/2006	US7125689 Method for rendering streptokinase less immunogenic to a human
10/24/2006	US7125687 Presenilin enhancers assays
10/24/2006	US7125686 Proteins and methods for producing the proteins
10/24/2006	US7125678 Protein biopolymer markers predictive of type II diabetes
10/24/2006	US7125676 Modified human sodium channel type 1 alpha subunit (SCN1A) nucleic acid that encodes an SCN1A voltage-gated sodium channel polypeptide that regulates Na+ ion membrane permeation; identifying a sodium channel modulator
10/24/2006	US7125670 Comprises activated CD4 T-cells (ACT-4-L) ligand polypeptide for detection of immunomodulators; autoimmune diseases; drug screening; immunosuppressants; viricides
10/24/2006	US7125663 Genes, compositions, kits and methods for identification, assessment, prevention, and therapy of cervical cancer
10/24/2006	US7125557 Isolated haemocyanin polypeptide having a specific amino acid sequence recombinantly expressed in a host cell, wherein the glycosylation pattern is different from naturally occurring KLH from Megathura crenulata; may be bonded to a virus, bacteria, DNA, carbohydrate, peptide or glycoprotein
10/24/2006	US7125551 Compound for use inthe diagnosis and treatment of cancer, viral, asthmatic, autoimmune, organ transplant rejection and infections
10/24/2006	US7125541 Administering targeting agent operatively attached to a therapeutic agent, and wherein the targeting agent recognizes and binds to a tumor-associated endothelial cell marker
10/19/2006	WO2006110760A2 Compositions and methods for the diagnosis and treatment of tumor
10/19/2006	WO2006110449A2 Agglomeration protein cascades, compositions and methods regarding the same
10/19/2006	WO2006110292A2 Temperature-triggered immobilization and purification of antibodies
10/19/2006	WO2006110182A2 Orthogonal translation components for the in vivo incorporation of unnatural amino acids
10/19/2006	WO2006109781A1 Process for production of glycoprotein composition
10/19/2006	WO2006109751A1 Method for producing protein by cell-free protein synthesis system
10/19/2006	WO2006109696A1 Composition comprising genetically engineered follicle-stimulating hormone
10/19/2006	WO2006109695A1 Composition comprising genetically engineered haptoglobin
10/19/2006	WO2006109599A1 Antibody reactive specifically to age derived from 3,4-dge
10/19/2006	WO2006109533A1 Method for production of antibody directed against cell membrane surface antigen epitope and assaying method
10/19/2006	WO2006109192A2 Antifungal bifunctional molecules, methods of construction and methods of treating fungal infection therewith
10/19/2006	WO2006074194A3 Engineered phosphite dehydrogenase mutants for nicotinamide cofactor regeneration
10/19/2006	WO2006065975B1 Methods of treating ankylosing spondylitis using anti-tnf antibodies and peptides of human tumor necrosis factor
10/19/2006	WO2006062398A3 Methods for the production and secretion of modified peptides
10/19/2006	WO2004084810A3 Novel imidazoline receptor homologs
10/19/2006	WO2004074302A3 Autosomal recessive polycystic kidney disease nucleic acids and peptides
10/19/2006	WO2003027637A3 Assessment of neurons in the arcuate nucleus to screen for agents that modify feeding behavior
10/19/2006	US20060236418 Genetically modified non-human mammals and cells
10/19/2006	US20060236417 Germinal center-associated nuclear protein (GANP); high affinity antibody; humanizing
10/19/2006	US20060236414 Proteases and methods for producing them
10/19/2006	US20060236412 Porcine uroplakin ii promoter and the production method of useful proteins using said promoter
10/19/2006	US20060236411 Antagonists il-15
10/19/2006	US20060236410 Protein specific for cardiac and skeletal muscle
10/19/2006	US20060235207 Antibodies against lesion tissue
10/19/2006	US20060235202 Neuronal polypeptide for use as antinociceptive, anesthetic and analgesic agents; receptor binding assay; vector; host cell
10/19/2006	US20060235201 Enduring T cell response
10/19/2006	US20060235200 Mutagenesis of aspergillus fungi and identification of genes essential for growth
10/19/2006	US20060235115 Bioadhesives comprising glycocalyx-containing fermentation residue for replacing phenol-formaldehyde components in plywood production
10/19/2006	US20060234967 Human protooncogene and protein encoded therein
10/19/2006	US20060234929 Rasgap derived peptide for selectively killing cancer cells
10/19/2006	US20060234928 Cell death-inducing fused gene acting specifically on cancer and gene product thereof
10/19/2006	US20060234926 Nucleic acid ligands and uses therefor
10/19/2006	US20060234924 A kit for screening a compound or its salt that promotes or inhibits the activity of the proteins; drug screening for hyperlipemia, arteriosclerosis, genital, digestive, respiratory diseases, renal, pancreatic, central nerve, respiratory, inflammatory, rheumatoid diseases and diabetic neurosis
10/19/2006	US20060234917 glycoprotein comprising the extracellular domain of a non-naturally occurring BAFF-R; BAFF (B-cell-activating factor of the TNF family); immunologic, autoimmune diseases, cancers, virus-associated diseases, renal, hypertensive diseases, conditions requiring immunosuppression, inflammation
10/19/2006	US20060234367 Yeast cells; ribonuclease barnase marker gene; libraries; drug resistance
10/19/2006	US20060234357 Expression vector comprising nucleotide sequences associated with amino acid biosynthesis for transformation and propagation in cells; enhancing concentration of amino acids for use in medicines, animal feeds and cosmetics; bioreactors
10/19/2006	US20060234356 Novel polynucleotides encoding useful polypeptides in corynebacterium glutamicum ssp. lactofermentum
10/19/2006	US20060234355 Alpha-agarase and process for producing the same
10/19/2006	US20060234352 Homogeneity and secretion of recombinant proteins in mammalian systems
10/19/2006	US20060234351 Yeast protein expression secretion system
10/19/2006	US20060234350 Endogenous and non-endogenous versions of human G protein-coupled receptors
10/19/2006	US20060234349 Fungal cell wall synthesis gene
10/19/2006	US20060234348 Method of production of RNA polymerase protein
10/19/2006	US20060234347 Targeting multiple angiogenic pathways for cancer therapy using soluble tyrosine kinase receptors
10/19/2006	US20060234346 Expression of mammalian proteins in Pseudomonas fluorescens
10/19/2006	US20060234345 Expression of soluble, active eukaryotic glycosyltransferases in prokaryotic organisms
10/19/2006	US20060234344 Protein kinases
10/19/2006	US20060234343 deletion of residues in the CR2 domain of the EGFR ectodomain gives rise to a truncated ectodomain with enhanced affinity for epidermal growth factors such as (EGF) and/or transforming growth factor-I (TGF- alpha ); psoriasis and tumor states
10/19/2006	US20060234342 Human DNA topoisomerase I alpha
10/19/2006	US20060234341 Process for producing phosphorylase
10/19/2006	US20060234340 Human heavy chain antibody expression in flamentous fungi
10/19/2006	US20060234339 Method of expressing protein having unnatural amino acid integrated thereinto
10/19/2006	US20060234338 transformant obtained by introducing a foreign gene into a microorganism which belongs to Aspergillus which lacks an alpha -glucosidase B gene; capable of producing a target protein with high productivity; efficiency

1 ... 379 380 381 382 383 384 385 386 387 388 389 390 391 392 393 394 395 396 397 398 399 ... 1125